Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8951
Southside Bancshares
SBSI
$950M
| $341K | ﹤0.01% |
+10,999
| New | +$317K |
|
8952
PUT
Steris
STE
$22.8B
| $341K | ﹤0.01% |
1,800
-12,900
| -88% | -$2.41M |
|
8953
Usana Health Sciences
USNA
$259M
| $341K | ﹤0.01% |
+4,426
| New | +$342K |
|
|
SASR
8954
PUT
DELISTED
Sandy Spring Bancorp Inc
SASR
| $341K | ﹤0.01% |
10,600
-1,300
| -11% | -$37.1K |
|
|
DEN
8955
DELISTED
Denbury Inc.
DEN
| $341K | ﹤0.01% |
+13,283
| New | +$270K |
|
8956
Invesco DB Oil Fund
DBO
$258M
| $340K | ﹤0.01% |
40,367
-1,998
| -5% | -$15.1K |
|
8957
PUT
Insmed
INSM
$25.9B
| $340K | ﹤0.01% |
10,200
-34,200
| -77% | -$1.25M |
|
8958
iShares US Small Cap Value Factor ETF
SVAL
$211M
| $340K | ﹤0.01% |
+13,813
| New | +$317K |
|
8959
CALL
Veeco
VECO
$2.71B
| $340K | ﹤0.01% |
19,600
-5,700
| -23% | -$87.1K |
|
|
RSXJ
8960
DELISTED
VanEck Russia Small-Cap ETF
RSXJ
| $340K | ﹤0.01% |
9,443
-4,482
| -32% | -$154K |
|
|
AVDL
8961
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $339K | ﹤0.01% |
50,700
-42,700
| -46% | -$267K |
|
|
CPRX
8962
DELISTED
Catalyst Pharmaceutical
CPRX
| $339K | ﹤0.01% |
101,646
+6,545
| +7% | +$22K |
|
|
NAK
8963
PUT
Northern Dynasty Minerals
NAK
$944M
| $339K | ﹤0.01% |
1,053,300
-1,186,300
| -53% | -$858K |
|
8964
CALL
Surgery Partners
SGRY
$1.79B
| $339K | ﹤0.01% |
11,700
-28,500
| -71% | -$709K |
|
8965
Tennant Co
TNC
$1.19B
| $339K | ﹤0.01% |
+4,836
| New | +$317K |
|
8966
Aquestive Therapeutics
AQST
$630M
| $338K | ﹤0.01% |
63,174
-63,438
| -50% | -$380K |
|
8967
Arrow Electronics
ARW
$10.4B
| $338K | ﹤0.01% |
3,469
-13,327
| -79% | -$1.18M |
|
|
MRSN
8968
PUT
DELISTED
Mersana Therapeutics
MRSN
| $338K | ﹤0.01% |
508
-4,720
| -90% | -$2.62M |
|
8969
Oxford Square Capital
OXSQ
$146M
| $338K | ﹤0.01% |
110,799
+6,989
| +7% | +$19.8K |
|
8970
ProShares S&P 500 ex-Financials ETF
SPXN
$79.9M
| $338K | ﹤0.01% |
8,438
-6,820
| -45% | -$260K |
|
|
TIGR
8971
CALL
UP Fintech Holding
TIGR
$906M
| $338K | ﹤0.01% |
42,600
-20,900
| -33% | -$116K |
|
8972
ProShares UltraShort Yen
YCS
$30.3M
| $338K | ﹤0.01% |
19,956
-47,200
| -70% | -$820K |
|
|
WIRE
8973
DELISTED
Encore Wire Corp
WIRE
| $338K | ﹤0.01% |
+5,582
| New | +$288K |
|
|
JNCE
8974
CALL
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $338K | ﹤0.01% |
48,300
-43,100
| -47% | -$335K |
|
|
DSL
8975
PUT
DoubleLine Income Solutions Fund
DSL
$1.22B
| $337K | ﹤0.01% |
20,300
-59,100
| -74% | -$960K |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.